Clinical trials recruiting in Langenau, Germany

Phase breakdown

Conditions recruiting in Langenau, Germany

Recruiting trials in Langenau, Germany

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
  NCT06807424 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis
  NCT06039241 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female)
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
  NCT06988605 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Langenau, Germany?

4 recruiting trials have at least one study site in Langenau, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.